コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 using relative peak areas with cannabinol as reference compound.
2 relative retention times with cannabinol as reference compound.
3 high-affinity GABAA antagonist was used as a reference compound.
4 that required for CA-4P, which was used as a reference compound.
5 in vivo in comparison to a (all amide bond) reference compound.
6 X, XII, and XIV using acetazolamide (AAZ) as reference compound.
7 -(AHX-DTPA-111In)NH2]exendin-4 was used as a reference compound.
8 mpound was confirmed by analysis of the pure reference compound.
9 to be at least 10-fold more potent than the reference compound.
10 comparable to that of letrozole chosen as a reference compound.
11 ty were calculated using alpha-tocopherol as reference compound.
12 he relative rate technique, with methanol as reference compound.
13 pared with butylated hydroxytoluene (BHT) as reference compound.
14 citrin (quercetin-3-O-rhamnoside), used as a reference compound.
15 l space sampled by ligands with respect to a reference compound.
16 th cyclopropane to produce a six-member ring reference compound.
17 the SE of the corresponding six-member ring reference compound.
18 -carboxamide) and the S = 0 [Fe(PaPy3)CO](+) reference compound.
19 ith cyclopropane to form a six-membered ring reference compound.
20 d linear combination analysis of known XANES reference compounds.
21 sed to monitor the concentrations of CPA and reference compounds.
22 ms, and delivered expected IC(50) values for reference compounds.
23 orders of magnitude lower than the relevant reference compounds.
24 ations and experimental data for appropriate reference compounds.
25 l shifts and by direct addition of authentic reference compounds.
26 polation of the loss kinetics of performance reference compounds.
27 using, e.g., the chlorinated derivatives as reference compounds.
28 mentally measured mass spectra from chemical reference compounds.
29 fects of ethanol extract of DP (EDP) and its reference compounds.
30 der spectrum of activity than numerous other reference compounds.
31 ng HRGC-O, in comparison with the respective reference compounds.
32 and IR analysis of the isolated cofactor and reference compounds.
33 alues of desirable low molecular weight (MW) reference compounds.
34 on cycloalkanes, cycloalkenes, and selected reference compounds.
35 ns the same characteristics as those the two reference compounds.
36 igh delta selectivity, H-Dmt-Tic--Lys(Z)-OH (reference compound 1) is a useful starting point for the
37 to the conformationally constrained 4-7 and reference compounds 1-3 catalyzed by alpha-2,6- and alph
38 exhibited comparable binding affinity to the reference compound, 1-(4-methoxybenzyl)-4-oxo-1,4-dihydr
40 nformationally constrained 6 and 7 and their reference compounds 2 and 3 further supports the fact th
41 tion conditions have been optimized using as reference compounds 2-, 3-, 4-, or 6-monosubstituted man
42 sitivity of (68)Ga-OPS202, compared with the reference compound, (68)Ga-DOTATOC (an sst receptor agon
43 e mere addition of a key moiety found in the reference compound 7 (ABT-239) elevated the series to hi
44 porfiromycin C(8) cyclized imine (6) and its reference compound, 7-N-(1'-aminocyclohex-2'-yl)porfirom
45 ve are ca. 10 000 times more potent than the reference compound acyclovir and ca. 100 times more pote
46 ld enhancement in anti-VZV activity over the reference compound acyclovir, with no detectable in vitr
47 mutants analogous to those achieved with the reference compound ambroxol were attained with a more fa
48 comparable to what could be achieved by the reference compound and current clinical candidate TPCS(2
49 cterized in biological data sets to those of reference compounds and (ii) putative identification fro
50 by Pb L3-edge XANES measurements using solid reference compounds and also aqueous solutions of differ
51 tical comparison with chemically synthesized reference compounds and electrospray ionization-mass spe
54 switches between the analyte and a standard reference compound, and leads to gaps in the analyte dat
55 10 AR transactivation assays, 72 ER-binding reference compounds, and the in vivo uterotrophic assay.
56 57 strong activators (greater activity than reference compound apigenin), most of which were unrelat
58 l ligands--one of the analyte and two of the reference compound) are collisionally activated, and the
59 these compounds and, by comparison with the reference compound BaMn2Bi2, we show that the Dirac carr
60 termined in vitro intrinsic clearance of six reference compounds (benzo[a]pyrene, 4-nonylphenol, di-t
62 been estimated relative to six-membered ring reference compounds by dimerization of dioxirane and or
63 l diffusivities of the two chemically stable reference compounds, caffeine and testosterone, were (1-
64 fragment ions and neutral losses to related reference compounds contained in METLIN, even if the pre
65 s analog may be chosen as NMR chemical shift reference compounds depending on the nature of the biomo
66 ectra of soil samples, along with a range of reference compounds differing in V-oxidation state and c
68 f the caffeinyl core and substituents of the reference compound (E)-8-(3-chlorostyryl)caffeine led to
70 ing study was carried out on the analogs and reference compound (Erlotinib) into the ATP binding site
77 roteolytic fragments provide a useful set of reference compounds for analysis of the LPO(N) and LPO(C
78 (III) and Ru(III) analogues were prepared as reference compounds for assessing the effect of the 5d v
79 ing benzhydrylium ions, which can be used as reference compounds for characterizing a wide variety of
82 gonist activity in the T47D assay, while the reference compounds from other related nonsteroidal hPR
84 displaying a lower potency in vitro than the reference compound GS39783, the new compounds 6, 10, and
86 Competition kinetics with phenylalanine as a reference compound in pulse radiolysis experiments yield
87 ladders have been constructed of appropriate reference compounds in dichloromethane and in acetonitri
90 s-glutathione conjugate and a monofunctional reference compound indicates that the bivalent inhibitor
93 igands-2 mol of the analyte and 1 mol of the reference compound) is collisionally activated and under
94 simultaneously and separately in relation to reference compounds it is possible to make quantitative
95 On the basis of the availability of these reference compounds, it was shown that the metabolic hyd
96 ol, norepinephrine, propranolol) with chiral reference compounds (L-amino acids) are generated by ele
98 parable or superior to the clinically tested reference compound [Lys40-(AHX-DTPA-111In)NH2]exendin-4
99 cting mu opioid receptor antagonist, and the reference compound methylnaltrexone, upon POI were inves
100 urements confirmed the results obtained from reference compounds, model samples, and real-world speci
102 tion and identification by using enantiopure reference compounds of eleven racemic TAGs with C12-C22
106 diffusive retardation factors as performance reference compounds (PRCs) that are diffusing out of the
107 strips that were preloaded with performance reference compounds (PRCs) were codeployed for 32 d alon
111 e in which a chiral analyte (A) and a chiral reference compound (ref*) are simultaneously coordinated
112 n branching ratios measured when pure chiral reference compounds (ref*D and ref*L) are employed in se
114 an, rat, and mouse, which were "spiked" with reference compound solutions at known concentrations.
115 best-fit transformations between signals in reference compound spectra and the corresponding signals
116 nce is typically calibrated by addition of a reference compound such as 3-(trimethylsilyl)-propionic
119 demonstrated through direct comparison with reference compounds that the presence of a fluorine atom
123 rolyte compositions, comparable to a neutral reference compound, (v) the protonated weak base was str
128 polyethylene (LDPE) loaded with performance reference compounds were applied independently to measur
130 of pyrene and deuterated pyrene (performance reference compound) were within 0.1 log unit for all exp
131 known experimental log Ko/w values served as reference compounds, whereas the PCB compounds without k
132 taDeltalogR) were calculated relative to the reference compound WIN55,212-2 for Galphai/o, Galphas, G
136 structures to be solved in complex with the reference compound ZM241385 and four related ligands at
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。